BayBio2010 | Advisory Board
Confirmed as of 12.23.09
- Bonnie Anderson
CEO, Veracyte, Inc.
- Sharon Barbari
EVP Finance and CFO, Cytokinetics, Inc.
- Kareem Dossa
Vice President – West, VWR International, LLC
- Rekha Hemrajani
Vice President, Business Development, Exelixis, Inc.
- Neal Gutterson
President and Chief Executive Officer, Mendel Biotechnology
- Jeffery Lange
Vice President Business Development, SciClone Pharmaceuticals, Inc.
- John McSherry
Pharma Partner Executive, Baxter Healthcare Corporation
- Matthew Mealiffe
Principal, Clinical Utility Consulting, LLC
Former Director, Clinical Research, Perlegen Sciences, Inc.
- M. Patrick Reichenberger
Director, Commercial Development, XOMA, LLC
- Aaron Schuchart
Vice President, Corporate Development & Strategy, Mendel Biotechnology
- Howard Simon
Sr. Vice President, Human Resources & Corporate Services & Associate General Counsel, InterMune, Inc.
- Mary Stutts
Senior Vice President, Corporate Relations, Elan Pharmaceuticals, Inc.
BayBio2010 Conference Planning Committee Co-Chairs:
- Melissa Kim
Manager, Market Analysis & Intelligence, Genentech, Inc.
- David Yeary
Director, Practice Development, Morgan Lewis & Bockius LLP
BayBio2010 Conference Planning Committee Members:
- Cassie Arnold
Principal, KMA & Company
- Sean Boyle
King & Spalding LLP
- Jack Florio
Senior Vice President, Brinson Patrick Securities Corporation
- Harry Georgiades
Director, Regional Operations, Integrated Project Management Company
- Selin Gurses - Acar
PriceWaterhouseCoopers, LLP
- Bruce Jenett
Co-Chair, Global Life Sciences Sector, DLA Piper US LLP
- Ravi Kiron
Managing Partner, Adjuvant Global Advisors, LLC
- Antoinette Konski
Partner, Foley & Lardner LLP
- Dawn Kwok
- Robert Sakai
Technology & Trade Director, East Bay Economic Development Alliance
- Joanna Schulman
Principal, Managing Partner, Thallo Bioscience Advisors, LLC
- Michael Schuppenhauer
Principal, Silver Hill Partners
- Shelley Trimm
President, RCQ Consulting
- Ken Wechsler
Principal, Remedy Compensation Consulting
